PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14651944-2	2004	In the present study, it is shown that serotonin (5-HT), as well as the selective 5-HT(1A) receptor agonist R-DPAT, increase cell survival and S phase transition in mouse splenocytes stimulated by T or B cell mitogens.	r-dpat	108-114	5-hydroxytryptamine (serotonin) receptor 1A	Mus musculus	82-99	
14651944-4	2004	Additionally, 5-HT and R-DPAT treatment increased intranuclear levels of the p50 and p65 subunits of NF-kappaB.	r-dpat	23-29	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	77-80	
14651944-4	2004	Additionally, 5-HT and R-DPAT treatment increased intranuclear levels of the p50 and p65 subunits of NF-kappaB.	r-dpat	23-29	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	85-88	
14651944-4	2004	Additionally, 5-HT and R-DPAT treatment increased intranuclear levels of the p50 and p65 subunits of NF-kappaB.	r-dpat	23-29	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	101-110	
14651944-5	2004	Potentiation by 5-HT and R-DPAT of mitogen-activated cell survival, S phase transition, and nuclear localization of NF-kappaB, as well as inhibition of apoptosis, were all reversed by the selective 5-HT(1A) receptor antagonist WAY-100635.	dpat	27-31	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	116-125	
14651944-5	2004	Potentiation by 5-HT and R-DPAT of mitogen-activated cell survival, S phase transition, and nuclear localization of NF-kappaB, as well as inhibition of apoptosis, were all reversed by the selective 5-HT(1A) receptor antagonist WAY-100635.	dpat	27-31	5-hydroxytryptamine (serotonin) receptor 1A	Mus musculus	198-215